15-Year Experience of Patch Testing during Pregnancy: Retrospective Case-Control Study from a Tertiary Israeli Center
Dermatology · 12.03.2026 · 242 (4) · 365-371
DOI: 10.1159/000551449 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Dermatology, online erschienen am 12.03.2026. Verfasst von Daniel Hilewitz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, Rabin Medical Center, Petach Tikva, Israel. Hauptthemen laut MEDLINE: Patch Tests, Dermatitis, Allergic Contact, Pregnancy Complications. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Although patch testing (PT) is not contraindicated during pregnancy, most dermatologists defer testing due to lack of data and possibility that immunological changes might influence outcomes. In our center, we routinely perform PT during pregnancy as it is not known to be teratogenic and may lead to significant improvements in quality of life. This study aimed to assess whether pregnancy alters the outcome of PT.
Methods
Retrospective, single-center case-control study was conducted at a tertiary Israeli dermatology clinic (2009–2023). Women who gave birth within 40 weeks of PT were identified, and for each, three age-, year-, and atopic dermatitis-matched controls were selected.
Results
Of 3,351 women tested, 54 (1.6%) were pregnant at the time of PT. Most were tested during the first trimester (63%). No significant differences were found in the frequency of positive patch test reactions between pregnant women and matched controls. The most common allergens in pregnant patients were nickel sulfate (61.1%), 2-hydroxyethyl methacrylate (13.64%), and fragrance mix II (5.5%).
Conclusion
Pregnancy does not appear to affect patch test outcomes in early and mid-gestation. Due to limited third-trimester representation, further studies are needed to determine whether reactivity remains consistent throughout all stages of pregnancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Dermatology, Rabin Medical Center, Petach Tikva, Israel.
- Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- Department of Obstetrics and Gynaecology, Shamir (Assaf Harofeh) Medical Center, Tel Aviv, Israel.
- Department of Dermatology, Sheba Medical Center, Ramat Gan, Israel.
- Division of Dermatology, Rabin Medical Center, Petach Tikva, Israel, IgorSn@clalit.org.il.
- Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, IgorSn@clalit.org.il.
Zitieren
APA
Hilewitz, D., Trattner, A., Noyman, Y., Radinsky, I. I., Ben Simon, N., Galili, E., Sherman, S., Mimouni, D., & Snast, I. (2026). 15-Year Experience of Patch Testing during Pregnancy: Retrospective Case-Control Study from a Tertiary Israeli Center. Dermatology, 242(4), 365-371. https://doi.org/10.1159/000551449
Vancouver
Hilewitz D, Trattner A, Noyman Y, Radinsky II, Ben Simon N, Galili E, et al. 15-Year Experience of Patch Testing during Pregnancy: Retrospective Case-Control Study from a Tertiary Israeli Center. Dermatology. 2026;242(4):365-371. doi:10.1159/000551449
BibTeX
@article{Hilewitz2026,
author = {Hilewitz, Daniel and Trattner, Akiva and Noyman, Yehonatan and Radinsky, Igal Igor and Ben Simon, Nuriel and Galili, Eran and Sherman, Shany and Mimouni, Daniel and Snast, Igor},
title = {15-Year Experience of Patch Testing during Pregnancy: Retrospective Case-Control Study from a Tertiary Israeli Center},
journal = {Dermatology},
year = {2026},
volume = {242},
number = {4},
pages = {365--371},
doi = {10.1159/000551449}
}
EUVIMED